Cargando…
Trophoblast glycoprotein is a marker for efficient sorting of ventral mesencephalic dopaminergic precursors derived from human pluripotent stem cells
Successful cell therapy for Parkinson’s disease (PD) requires large numbers of homogeneous ventral mesencephalic dopaminergic (vmDA) precursors. Enrichment of vmDA precursors via cell sorting is required to ensure high safety and efficacy of the cell therapy. Here, using LMX1A-eGFP knock-in reporter...
Autores principales: | Yoo, Jeong-Eun, Lee, Dongjin R., Park, Sanghyun, Shin, Hye-Rim, Lee, Kun Gu, Kim, Dae-Sung, Jo, Mi-Young, Eom, Jang-Hyeon, Cho, Myung Soo, Hwang, Dong-Youn, Kim, Dong-Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289854/ https://www.ncbi.nlm.nih.gov/pubmed/34282148 http://dx.doi.org/10.1038/s41531-021-00204-8 |
Ejemplares similares
-
Clonal Human Fetal Ventral Mesencephalic Dopaminergic Neuron Precursors for Cell Therapy Research
por: Ramos-Moreno, Tania, et al.
Publicado: (2012) -
Migratory defect of mesencephalic dopaminergic neurons in developing reeler mice
por: Kang, Woo-Young, et al.
Publicado: (2010) -
Panning for gold: Purifying mesencephalic dopaminergic progenitors differentiated from human pluripotent stem cells
por: Tang, Qingyuan, et al.
Publicado: (2022) -
Characterization of Porcine Ventral Mesencephalic Precursor Cells following Long-Term Propagation in 3D Culture
por: Jensen, Pia S., et al.
Publicado: (2012) -
Trophoblast glycoprotein is a new candidate gene for Parkinson’s disease
por: Park, Sanghyun, et al.
Publicado: (2021)